The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer

Tong Liu,Yali Fan,Qingsong Zhang,Yiming Wang,Nan Yao,Mengmeng Song,Qi Zhang,Liying Cao,Chunhua Song,Hanping Shi
DOI: https://doi.org/10.1007/s00011-022-01597-9
IF: 6.986
2022-06-19
Inflammation Research
Abstract:Inflammation and metabolic syndrome (MetS) may act synergistically and possibly accelerate the initiation and progression of colorectal cancer (CRC). We prospectively examined the joint effect of MetS and inflammation on the risk of CRC.
immunology,cell biology
What problem does this paper attempt to address?